RxDoctor Payments Data

Amanda Hall

Nurse Practitioner · Fleming Island, FLNPI 1548771678

Payments from drug & device makers

$14,557in general payments, 2019–2025

Across 814 payments — averaging $17.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Novartis$1K
  • SK Life Science, Inc.$924
  • Pfizer$838
  • Lilly USA, LLC$638
  • Eisai Inc.$608
  • plus $8K from 51 others

What the payments were for

  • Food & beverage$14,36699%
  • Education$1911%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,557 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
UbrelvyUbrogepant27$44,357
QuliptaAtogepant22$28,792
BotoxOnabotulinumtoxina13$16,839
ZavzpretZavegepant Hcl11$11,570
Gabapentin51$689
Rasagiline Mesylate11$496
Duloxetine Hcl16$312
Primidone20$237
Donepezil Hcl31$182

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy, Qulipta, Botox$2,741$89,98862 claims
PfizerZavzpret$838$11,57011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,290 nurse practitioner providers in Florida.

Other nurse practitioner in Fleming Island

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →